Viewing Study NCT03647592


Ignite Creation Date: 2025-12-24 @ 3:17 PM
Ignite Modification Date: 2026-01-13 @ 12:17 PM
Study NCT ID: NCT03647592
Status: RECRUITING
Last Update Posted: 2023-12-27
First Post: 2018-08-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Sponsor: Hunan Province Tumor Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module